Trastuzumab emtansine is a HER2-targeted antibody-drug conjugate used in the treatment of HER2-positive breast cancer. This therapeutic agent functions by combining the monoclonal antibody trastuzumab… Read more
Trastuzumab emtansine is a HER2-targeted antibody-drug conjugate used in the treatment of HER2-positive breast cancer. This therapeutic agent functions by combining the monoclonal antibody trastuzumab with the cytotoxic chemotherapy agent DM1, allowing for the direct delivery of the payload to tumor cells that overexpress the human epidermal growth factor receptor 2. Our category of Trastuzumab emtansine related compounds includes essential reference standards, impurities, metabolites, and stable isotope labelled compounds specifically designed for analytical testing and quality control. These high-quality materials support laboratories in critical processes such as impurity profiling, method validation, and the precise quantification of drug components. By utilizing these standards, pharmaceutical researchers can ensure the safety and efficacy of their formulations, effectively navigating the complexities of antibody-drug conjugate characterization throughout the manufacturing lifecycle.